# Clofarabine/Ara-C Treatment Combined With Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Treatment Failure

> **NCT01188174** · PHASE2 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 26 (actual)

## Conditions studied

- AML

## Interventions

- **DRUG:** Clofarabine

## Key facts

- **NCT ID:** NCT01188174
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01188174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01188174, "Clofarabine/Ara-C Treatment Combined With Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Treatment Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01188174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*